CN102488685B - 含复方氨基酸成分的脂质体制剂的应用方法 - Google Patents
含复方氨基酸成分的脂质体制剂的应用方法 Download PDFInfo
- Publication number
- CN102488685B CN102488685B CN 201110451562 CN201110451562A CN102488685B CN 102488685 B CN102488685 B CN 102488685B CN 201110451562 CN201110451562 CN 201110451562 CN 201110451562 A CN201110451562 A CN 201110451562A CN 102488685 B CN102488685 B CN 102488685B
- Authority
- CN
- China
- Prior art keywords
- amino acid
- vitamin
- wound
- parts
- ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 23
- -1 compound amino acid Chemical class 0.000 title claims abstract description 7
- 239000002502 liposome Substances 0.000 title abstract description 13
- 206010052428 Wound Diseases 0.000 claims abstract description 61
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 61
- 150000001413 amino acids Chemical class 0.000 claims abstract description 28
- 239000004033 plastic Substances 0.000 claims abstract description 11
- 229920003023 plastic Polymers 0.000 claims abstract description 11
- 230000001684 chronic effect Effects 0.000 claims abstract description 10
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 9
- 230000001154 acute effect Effects 0.000 claims abstract description 8
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims abstract description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 47
- 229940024606 amino acid Drugs 0.000 claims description 27
- 235000001014 amino acid Nutrition 0.000 claims description 27
- 238000009472 formulation Methods 0.000 claims description 24
- 238000004659 sterilization and disinfection Methods 0.000 claims description 16
- 230000001954 sterilising effect Effects 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 11
- 230000005855 radiation Effects 0.000 claims description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 5
- 206010011985 Decubitus ulcer Diseases 0.000 claims description 4
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 4
- 208000025865 Ulcer Diseases 0.000 claims description 4
- 235000012000 cholesterol Nutrition 0.000 claims description 4
- 239000008347 soybean phospholipid Substances 0.000 claims description 4
- 231100000397 ulcer Toxicity 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- 241000195474 Sargassum Species 0.000 claims description 3
- 206010040943 Skin Ulcer Diseases 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 229930003448 Vitamin K Natural products 0.000 claims description 3
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 239000000783 alginic acid Substances 0.000 claims description 3
- 229960001126 alginic acid Drugs 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 150000004781 alginic acids Chemical class 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960001305 cysteine hydrochloride Drugs 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960005357 lysine acetate Drugs 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 229940069338 potassium sorbate Drugs 0.000 claims description 3
- 235000010241 potassium sorbate Nutrition 0.000 claims description 3
- 239000004302 potassium sorbate Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 231100000019 skin ulcer Toxicity 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 235000019168 vitamin K Nutrition 0.000 claims description 3
- 239000011712 vitamin K Substances 0.000 claims description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940046010 vitamin k Drugs 0.000 claims description 3
- 208000009084 Cold Injury Diseases 0.000 claims description 2
- 208000008960 Diabetic foot Diseases 0.000 claims description 2
- 206010053615 Thermal burn Diseases 0.000 claims description 2
- 206010044546 Traumatic ulcer Diseases 0.000 claims description 2
- 208000000558 Varicose Ulcer Diseases 0.000 claims description 2
- 230000002595 cold damage Effects 0.000 claims description 2
- 230000029663 wound healing Effects 0.000 abstract description 13
- 238000005516 engineering process Methods 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000010261 cell growth Effects 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 239000003102 growth factor Substances 0.000 abstract description 2
- 239000004411 aluminium Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000000249 desinfective effect Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000000472 traumatic effect Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010048629 Wound secretion Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了含复方氨基酸成分的脂质体制剂的应用方法，该方法是将通过201110442862.6号专利申请件制备的含复方氨基酸成分的脂质体制剂制成能够直接应用于各类急慢性伤口的产品，即将制剂灌装于铝管或铝塑管或塑料管中，每管装入1～500g，封尾，然后用钴－60辐射灭菌，制得含复方氨基酸成分的脂质体制剂的应用产品。本方法使采用特殊脂质体技术及成膜技术制备的制剂得以应用于伤口，优点是涂于创面后在较短时间内能形成一层膜，该膜能够为创面提供半密闭湿润透气的环境，有利于创面愈合；装载氨基酸等细胞生长因子的脂质体通过吸附、融合方式直接进入创面细胞内，参与细胞的新陈代谢，促进细胞生长与爬行；从而促进伤口愈合，缩短创面愈合时间。
Description
技术领域
本发明涉及以特殊物理形状为特征的医药配制品，特别涉及脂质体，具体来说，涉及含复方氨基酸成分的脂质体制剂的应用。
背景技术
脂质体技术的发展有近50年的历史，20世纪50年代，医学界的Odland(1958).Winter(1962).Hinman和Maibach（1963）分别通过他们的研究得出了同样的结论：保持湿润环境能够加速创面愈合。由于这一里程碑式的发现诞生了湿润环境愈合理论，湿性敷料逐渐成为伤口敷料的主流。2000年8月，美国FDA在新颁布的《创面医疗用品（外用药和敷料）的行业指南》以及中华医学会创伤学分会组织修复专业委员会编著的2011年本版《慢性伤口诊疗指导意见》中均特别强调：保持创面的湿润环境是标准的处理方法。
密闭性（湿性）敷料的推广使用大大加速了创面的愈合，既减轻了患者的痛苦，也降低了护理人员的工作强度。但是，由于湿性敷料的局限性（只能改善创面愈合的环境），大部分久治不愈的慢性伤口仍然是令临床医护工作者头痛的问题。
在湿性敷料基础上研究开发一种能为伤口愈合提供湿润密闭的环境，而且以脂质体为载体直接为创面细胞提供“脂质体靶向”营养，并且能够加快伤口愈合的速度，而且使大多数难愈性伤口的快速愈合成为可能，成了科研人员一直不断追求的目标。为此，发明人提供了含复方氨基酸成分的脂质体制剂配方及其制备方法，申请了专利，申请号201110442862.6。但尚未有这种含复方氨基酸成分的脂质体制剂的具体应用方法问世。
发明内容
本发明的目的是提供含复方氨基酸成分的脂质体制剂的应用方法，使脂质体得以实际应用，从而更好地为人类健康服务。
发明人提供的含复方氨基酸成分的脂质体制剂的应用方法，是将通过201110442862.6号专利申请件制备的含复方氨基酸成分的脂质体制剂制成能够直接应用于各类急慢性伤口的产品，即将制剂灌装于铝管或铝塑管或塑料管中，每管装入1～500g，封尾，然后用钴－60辐射灭菌，制得含复方氨基酸成分的脂质体制剂的应用产品。
上述方法中，含复方氨基酸成分的脂质体制剂是由大豆磷脂、胆固醇、氨基酸、维生素、防腐剂、成膜材料和工艺用水制成的，按1000份产品的配方为：大豆磷脂10～150份，胆固醇6～80份，盐酸半胱氨酸0.3～1.2份，色氨酸0.03～0.6份，缬氨酸 0.4～1.3份，异亮氨酸0.5～2.0份，亮氨酸0.8～2.5份，醋酸赖氨酸0.2～1.2份，蛋氨酸0.06～0.5份，苯丙氨酸0.09～0.7份，苏氨酸0.1～0.6份，精氨酸0.1～1.6份，甘氨酸0.2～2份，脯氨酸0.05～0.3份，维生素A 0.03～2份，维生素C 0.3～2份，维生素E 0.4～3份，维生素K 0.01～0.1份，成膜材料 65～200份，防腐剂山梨酸钾或尼泊金乙酯 0.5～4份，余为工艺用水；所述各种原料均为市售产品，所述成膜材料是海藻酸钠（褐澡酸钠）或海藻酸（褐澡酸）的衍生物或海藻多糖复合胶。该配方可以使用上述氨基酸中的几种或全部、上述维生素中的一种或全部。
上述方法中，所述用钴－60辐射灭菌的辐射剂量为4～40kGy，灭菌时间为3～30h。
上述方法中，所述急性伤口包括创伤、手术切口、皮肤磨削伤、烧伤、烫伤、冻伤等；所述慢性伤口包括压力性溃疡、动脉性溃疡、静脉性溃疡、糖尿病足溃疡、创伤性溃疡、皮肤溃疡等。
上述方法中，所述直接用于各类急慢性伤口的具体操作方法是将本制剂涂于事先清洁、消毒和清除坏死组织的创面上，使其边缘超出创面范围1cm左右向伤口及创面的组织提供营养，使其迅速愈合；创面较深者须增加涂抹厚度，等待7分钟左右即成膜；外加无菌纱布包扎。
发明人指出：在具体操作中应当注意：
1.使用本品前一般应按常规外科方法消毒及清洁创面，必要时用无菌纱布吸干创面分泌物。
2.打开包装按无菌要求，用75％酒精消毒帽尖后再刺穿启封。
3.取本制剂涂于创面上，使其边缘超出创面范围1cm左右；如创面较深，应适当增加涂抹厚度，等待7分钟左右即成膜；外加无菌纱布包扎。
4. 如果创面感染较深，使用本品时请结合抗炎治疗手段。
5．如创面渗出液较多，应先进行抗渗出治疗。
6. 一般每天涂抹一次，如无感染可直接涂抹。
本发明方法使采用特殊脂质体技术及成膜技术制备的制剂可以直接应用于伤口与创面，优点是涂于创面后在较短时间内能形成一层膜，该膜能够为创面提供半密闭湿润透气的环境，有利于创面愈合；装载氨基酸等细胞生长因子的脂质体通过吸附、融合的方式直接进入创面细胞内，参与细胞的新陈代谢，促进细胞的生长与爬行；从而促进伤口愈合，大大缩短创面愈合时间。
具体实施方式
现通过下列实施例详细说明本发明的具体实施方式。
实施例l 制备含复方氨基酸成分的脂质体制剂的第一种应用产品
按201110442862.6号专利申请件制备的含复方氨基酸成分的脂质体制剂灌装于铝管中，每管装入30g，折边封尾后进行外包装，然后用钴－60辐射灭菌，辐射剂量为16kGy，灭菌时间为15h，制得含复方氨基酸成分的脂质体制剂的应用产品。
实施例2 制备含复方氨基酸成分的脂质体制剂的第二种应用产品
按201110442862.6号专利申请件制备的含复方氨基酸成分的脂质体制剂灌装于铝塑管中，每管装入10g，热熔封尾后进行外包装，然后用钴－60辐射灭菌，辐射剂量为25kGy，灭菌时间为8h，制得含复方氨基酸成分的脂质体制剂的应用产品。
实施例3 制备含复方氨基酸成分的脂质体制剂的第三种应用产品
按201110442862.6号专利申请件制备的含复方氨基酸成分的脂质体制剂灌装于塑料管中，每管装入20g，热熔封尾后进行外包装，然后用钴－60辐射灭菌，辐射剂量为28kGy，灭菌时间为4h，制得含复方氨基酸成分的脂质体制剂的应用产品。
实施例4 应用于压力性溃疡
用生理盐水清洗患者压力性溃疡部位，打开实施例1的应用产品，按无菌要求，用75％酒精消毒帽尖后再刺穿铝管口启封。取铝管中的制剂涂于创面上，使其边缘超出创面范围1cm；如创面较深，应适当增加厚度，等待7分钟，成膜，外加无菌纱布包扎；同时结合抗炎治疗。创面渗出液较多时，应先进行抗渗治疗。每天涂抹1次，10天左右创面愈合。
实施例5 应用于创面
用生理盐水反复冲洗患者创面部位，先进行抗渗治疗，再打开实施例2的应用产品，按无菌要求，用75％酒精消毒帽尖后再刺穿铝塑管口启封。取铝塑管中的制剂涂于创面上，使其边缘超出创面范围1cm；创面较深者应适当增加厚度，等待7分钟，成膜，外加无菌纱布包扎；每天涂抹1次，如无感染，可直接涂抹，2周创面愈合。
实施例6 应用于皮肤溃疡
用生理盐水清洗患者溃疡部位，先对溃疡患处进行消毒处理，再打开实施例3的应用产品，按无菌要求，用75％酒精消毒帽尖后再刺穿塑料管口启封。取塑料管中的制剂涂于创面上，使其边缘超出创面范围1cm；每天涂抹1次，如无感染，可直接涂抹，6天左右创面愈合。
实施例7 应用于创伤伤口
用生理盐水反复冲洗患者创伤伤口部位，先对创伤伤口部位进行消毒处理，再打开实施例2的应用产品，按无菌要求，用75％酒精消毒帽尖后再刺穿铝塑管口启封。取铝塑管中的制剂涂于创面上，使其边缘超出创面范围1cm；创面较深者应适当增加厚度，等待7分钟，成膜，外加无菌纱布包扎；每天涂抹1次，如无感染，可直接涂抹，2天伤口愈合。
上述实施例仅列举了部分含复方氨基酸的脂质体制剂的应用方法实例，凡与本发明方法相似，无须付出创造性劳动的技术方案均在本申请件的保护范围之内。
Claims (2)
1.一种含复方氨基酸成分的脂质体制剂在制备治疗急性伤口和慢性伤口的产品中的应用方法，其特征在于将含复方氨基酸成分的脂质体制剂制成能够直接应用于各类急性伤口和慢性伤口的产品；所述含复方氨基酸成分的脂质体制剂按1000份产品的配方为：大豆磷脂10～150份，胆固醇6～80份，盐酸半胱氨酸0.3～1.2份，色氨酸0.03～0.6份，缬氨酸0.4～1.3份，异亮氨酸0.5～2.0份，亮氨酸0.8～2.5份，醋酸赖氨酸0.2～1.2份，蛋氨酸0.06～0.5份，苯丙氨酸0.09～0.7份，苏氨酸0.1～0.6份，精氨酸0.1～1.6份，甘氨酸0.2～2份，脯氨酸0.05～0.3份，维生素A0.03～2份，维生素C0.3～2份，维生素E0.4～3份，维生素K0.01～0.1份，褐藻酸钠或褐藻酸或海藻多糖复合胶65～200份，防腐剂山梨酸钾或尼泊金乙酯0.5～4份，余为工艺用水；所述急性伤口包括创伤、手术切口、皮肤磨削伤、烧伤、烫伤、冻伤；所述慢性伤口包括压力性溃疡、动脉性溃疡、静脉性溃疡、糖尿病足溃疡、创伤性溃疡、皮肤溃疡。
2.如权利要求1所述的应用方法，其特征在于所述治疗急性伤口和慢性伤口产品的制备是将含复方氨基酸成分的脂质体制剂用铝管或铝塑管或塑料管灌装，每管装入1～500g，封尾，然后用钴-60辐射灭菌，灭菌的辐射剂量为4～40kGy，灭菌时间为3～30h，其中所述含复方氨基酸成分的脂质体制剂按1000份产品的配方为：大豆磷脂10～150份，胆固醇6～80份，盐酸半胱氨酸0.3～1.2份，色氨酸0.03～0.6份，缬氨酸0.4～1.3份，异亮氨酸0.5～2.0份，亮氨酸0.8～2.5份，醋酸赖氨酸0.2～1.2份，蛋氨酸0.06～0.5份，苯丙氨酸0.09～0.7份，苏氨酸0.1～0.6份，精氨酸0.1～1.6份，甘氨酸0.2～2份，脯氨酸0.05～0.3份，维生素A0.03～2份，维生素C0.3～2份，维生素E0.4～3份，维生素K0.01～0.1份，褐藻酸钠或褐藻酸或海藻多糖复合胶65～200份，防腐剂山梨酸钾或尼泊金乙酯0.5～4份，余为工艺用水。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110451562 CN102488685B (zh) | 2011-12-30 | 2011-12-30 | 含复方氨基酸成分的脂质体制剂的应用方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110451562 CN102488685B (zh) | 2011-12-30 | 2011-12-30 | 含复方氨基酸成分的脂质体制剂的应用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102488685A CN102488685A (zh) | 2012-06-13 |
| CN102488685B true CN102488685B (zh) | 2013-05-01 |
Family
ID=46180592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110451562 Active CN102488685B (zh) | 2011-12-30 | 2011-12-30 | 含复方氨基酸成分的脂质体制剂的应用方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102488685B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106474529B (zh) * | 2015-08-28 | 2019-05-28 | 贵州扬生医用器材有限公司 | 一种含氨基酸脂质体的止血胶黏剂及其制备方法 |
| CN106474526B (zh) * | 2015-08-28 | 2019-08-06 | 贵州扬生医用器材有限公司 | 一种含脂质体的无定形水胶体敷料及其制备方法 |
| CN110292565B (zh) * | 2019-07-17 | 2021-09-03 | 邢瑞 | 不透过血脑屏障的脂质体复合物及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1298701A (zh) * | 1999-12-03 | 2001-06-13 | 中国人民解放军军事医学科学院放射医学研究所 | 新型复合氨基酸组合物 |
| CN1829504A (zh) * | 2003-05-30 | 2006-09-06 | 独立行政法人理化学研究所 | 氨基酸组合物及补液 |
| CN102190589A (zh) * | 2010-03-04 | 2011-09-21 | 中国科学院过程工程研究所 | 一种用于食品和医疗的氨基酸离子液体 |
-
2011
- 2011-12-30 CN CN 201110451562 patent/CN102488685B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1298701A (zh) * | 1999-12-03 | 2001-06-13 | 中国人民解放军军事医学科学院放射医学研究所 | 新型复合氨基酸组合物 |
| CN1829504A (zh) * | 2003-05-30 | 2006-09-06 | 独立行政法人理化学研究所 | 氨基酸组合物及补液 |
| CN102190589A (zh) * | 2010-03-04 | 2011-09-21 | 中国科学院过程工程研究所 | 一种用于食品和医疗的氨基酸离子液体 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102488685A (zh) | 2012-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6995765B2 (ja) | 医療用治療システムと共に使用されるドレープ | |
| JPH05505117A (ja) | 創傷の診断および治療用のシステム | |
| CN102488685B (zh) | 含复方氨基酸成分的脂质体制剂的应用方法 | |
| CN110507845A (zh) | 生物复合透气敷料及其制备方法 | |
| CN105086318B (zh) | 一种抗菌透明敷料及其制备方法和应用 | |
| CN103143052A (zh) | 医用胶原敷料及其制备方法和用途 | |
| CN204073041U (zh) | 透析导管保护套 | |
| CN103735370A (zh) | 一种新生儿脐带护理包 | |
| CN102247629A (zh) | 一次性血液透析护理包 | |
| CN107812179A (zh) | 一种还原型谷胱甘肽在制备治疗外伤涂沫药剂中的应用 | |
| JP2021014450A (ja) | タトゥーの色を維持し、強化する方法 | |
| CN106178068A (zh) | 一种促进伤口愈合的贴膜及缝合器 | |
| CN104352305B (zh) | 一种能够促进创口快速愈合的创口敷料 | |
| CN109985053A (zh) | 一种用于制备伤口愈合含维生素d成分组合物的方法 | |
| CN102697925A (zh) | 用于治疗耳部湿疹的中药组合物 | |
| CN108042845A (zh) | 一种白蛋白基水凝胶敷料及其制备方法 | |
| CN2511272Y (zh) | 伤口促愈贴 | |
| CN204411121U (zh) | 一种新生儿脐带护理包 | |
| CN202198901U (zh) | 一次性血液透析护理包 | |
| CN217040502U (zh) | 一种防内瘘感染的专用敷贴 | |
| CN203763542U (zh) | 胶原蛋白创可贴 | |
| CN203042644U (zh) | 一种芦荟伤口贴 | |
| CN102488587A (zh) | 一种聚氨酯医用防水贴 | |
| CN204601371U (zh) | 一种便携式止血消毒棉球 | |
| CN205359798U (zh) | 一种含有氧化再生纤维素的创可贴 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Application method of liposome preparation containing compound amino acid component Effective date of registration: 20141230 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2014520000005 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160329 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2014520000005 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Application method of liposome preparation containing compound amino acid component Effective date of registration: 20160407 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2016520000004 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170614 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2016520000004 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Application method of liposome preparation containing compound amino acid component Effective date of registration: 20170621 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2017520000005 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180704 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2017520000005 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Application method of liposome preparation containing compound amino acid component Effective date of registration: 20180723 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2018520000009 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190918 Granted publication date: 20130501 Pledgee: Guizhou Tianxin Company limited by guarantee Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: 2018520000009 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Application method of liposome preparation containing compound amino acid component Effective date of registration: 20191212 Granted publication date: 20130501 Pledgee: Bank of Guiyang, Limited by Share Ltd directly under the sub branch Pledgor: Guizhou Yangsheng Medical Instrument Co., Ltd. Registration number: Y2019520000014 |